Trial Profile
A phase I, prospective, double-blind, randomised, placebo-controlled, dose-escalating study to assess the safety and tolerability of single and multiple oral doses of PH46A and the effect of the fasted and fed state on pharmacokinetics of PH46A in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs PH 46A (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Trino Therapeutics
- 01 Sep 2014 According to the ISRCTN record, status changed from recruiting to completed.
- 15 Mar 2014 New trial record